XML 398 R90.htm IDEA: XBRL DOCUMENT v2.4.1.9
Earnings Per Share (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Sep. 30, 2014
Sep. 30, 2013
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]                          
Net income $ 50.0us-gaap_NetIncomeLoss $ 37.2us-gaap_NetIncomeLoss $ 36.4us-gaap_NetIncomeLoss $ 19.9us-gaap_NetIncomeLoss $ 18.8us-gaap_NetIncomeLoss $ 38.7us-gaap_NetIncomeLoss $ 37.2us-gaap_NetIncomeLoss $ 18.7us-gaap_NetIncomeLoss $ 279.1us-gaap_NetIncomeLoss $ 93.5us-gaap_NetIncomeLoss $ 143.5us-gaap_NetIncomeLoss $ 113.4us-gaap_NetIncomeLoss $ 107.1us-gaap_NetIncomeLoss
Weighted average shares for basic EPS                 112.3us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 112.3us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 97.0us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 97.0us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 97.0us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Dilutive potential shares from granted RSUs and PRSUs                 0.5us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements [1] 0.5us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements [1]      
Weighted average shares for diluted EPS                 112.8us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 112.8us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 97.0us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 97.0us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 97.0us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount                 0.1us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount        
[1] The potential impact of an aggregate 0.1 million granted RSUs, PRSUs and stock options for the nine months ended September 30, 2014, was antidilutive.